PRESS RELEASE published on 06/19/2024 at 21:15, 2 years 4 months ago Inside Information / Other news releases ABIONYX announces capital increase of c.€3.4 million with share issuance and warrants, strengthening financial position for Sepsis and US development, supported by ORSAY 53 investment company Capital Increase Share Issuance ABIONYX Sepsis Development ORSAY 53
BRIEF published on 06/13/2024 at 19:53, 2 years 4 months ago ABIONYX Pharma Receives FDA Approval for New Sepsis Study FDA Clinical Study ABIONYX Pharma Sepsis CER-001
PRESS RELEASE published on 06/13/2024 at 19:48, 2 years 4 months ago Inside Information / Other news releases ABIONYX Pharma completes successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial in Sepsis, marking significant progress in developing innovative therapy FDA ABIONYX Pharma Sepsis CER-001 Pre-IND Meeting
Published on 10/30/2026 at 23:35, 2 days 7 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 7 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 2 days 12 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 15 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/02/2026 at 07:05, 11 minutes ago Lazard Completes Its Acquisition of Campbell Lutyens and Launches Lazard CL, the Global Leader for the Next Era of Private Capital
Published on 11/02/2026 at 07:05, 11 minutes ago PolyPeptide Group: Provisional end result of the public tender offer of Samsung Biologics Co., Ltd.
Published on 11/02/2026 at 07:00, 16 minutes ago Arbonia adjusts outlook for 2026 and continues to expect solid development
Published on 11/02/2026 at 07:00, 16 minutes ago Medartis reports accelerating US momentum on faster adoption of TOUCH® thumb joint prosthesis
Published on 11/02/2026 at 07:00, 16 minutes ago Infracore SA: Infracore gives a binding commitment in the event that the Wetzikon Hospital composition agreement fails
Published on 10/30/2026 at 23:00, 2 days 8 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 18:00, 2 days 13 hours ago 2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 2 days 19 hours ago Capital increase through exercise of subscription rights
